Trial Profile

An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously participated in the PROUD-PV Study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 23 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Dec 2023 Results assessing treatment response in PROUD-PV and CONTINUATION-PV trials, presented at the 65th American Society of Hematology Annual Meeting and Exposition
07 Dec 2023 According to AOP Orphan Pharmaceuticals GmbH media release, data from the study will Be Presented at the American Society of Hematology (ASH) 65th Annual Meeting
19 Sep 2023 According to a an AOP Orphan Pharmaceuticals AG media release, data from CONTINUATION-PV and PROUD-PV presented at the Annual Meeting of the European Hematology Association and published in the journal Leukemia.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com